Researchers have spent more than three decades developing and studying miniature biosensors that can identify single molecules. In 5 to 10 years, when such devices may become a staple in doctors’ offices, they could detect molecular markers for cancer and other diseases and assess the effectiveness of drug treatment to fight those illnesses.
Click here for original story, Study suggests how to build a better ‘nanopore’ biosensor
Source: Phys.org